The high potency APIs market projected to grow from USD 24.15 billion in 2022 to USD 49.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9% during the forecast period (2023 - 2032).
The High Potency Active Pharmaceutical Ingredients (HPAPI) market is experiencing significant growth, driven by the rising demand for targeted therapies and the increasing prevalence...
0 Commentarios
0 Acciones
247 Views
0 Vista previa